These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31712813)

  • 1. Gentamicin Alone Is Inadequate to Eradicate Neisseria Gonorrhoeae From the Pharynx.
    Barbee LA; Soge OO; Morgan J; Leclair A; Bass T; Werth BJ; Hughes JP; Golden MR
    Clin Infect Dis; 2020 Nov; 71(8):1877-1882. PubMed ID: 31712813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.
    Kirkcaldy RD; Weinstock HS; Moore PC; Philip SS; Wiesenfeld HC; Papp JR; Kerndt PR; Johnson S; Ghanem KG; Hook EW
    Clin Infect Dis; 2014 Oct; 59(8):1083-91. PubMed ID: 25031289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods.
    Daly CC; Hoffman I; Hobbs M; Maida M; Zimba D; Davis R; Mughogho G; Cohen MS
    J Clin Microbiol; 1997 Nov; 35(11):2985-8. PubMed ID: 9350775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012-2016.
    Barbee LA; Soge OO; Katz DA; Dombrowski JC; Holmes KK; Golden MR
    Clin Infect Dis; 2018 Feb; 66(5):712-718. PubMed ID: 29045604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Neisseria gonorrhoeae DNA following treatment for pharyngeal and rectal gonorrhea is influenced by antibiotic susceptibility and reinfection.
    Bissessor M; Whiley DM; Fairley CK; Bradshaw CS; Lee DM; Snow AS; Lahra MM; Hocking JS; Chen MY
    Clin Infect Dis; 2015 Feb; 60(4):557-63. PubMed ID: 25371490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin Susceptibility in Neisseria gonorrhoeae and Treatment Outcomes for Urogenital Gonorrhea After 25 Years of Sustained Gentamicin Use in Malawi.
    Matoga M; Chen JS; Krysiak R; Ndalama B; Massa C; Bonongwe N; Mathiya E; Kamtambe B; Jere E; Chikaonda T; Golparian D; Unemo M; Cohen MS; Hobbs MM; Hoffman IF
    Sex Transm Dis; 2022 Apr; 49(4):251-256. PubMed ID: 34772893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT.
    Ross JD; Harding J; Duley L; Montgomery AA; Hepburn T; Tan W; Brittain C; Meakin G; Sprange K; Thandi S; Jackson L; Roberts T; Wilson J; White J; Dewsnap C; Cole M; Lawrence T
    Health Technol Assess; 2019 May; 23(20):1-104. PubMed ID: 31099330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin, azithromycin and ceftriaxone in the treatment of gonorrhoea: the relationship between antibiotic MIC and clinical outcome.
    Cole MJ; Tan W; Fifer H; Brittain C; Duley L; Hepburn T; Lawrence T; Montgomery AA; Sprange K; Thandi S; Churchward C; Tripodo F; Woodford N; Ross JDC
    J Antimicrob Chemother; 2020 Feb; 75(2):449-457. PubMed ID: 31670808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial.
    Rob F; Klubalová B; Nyčová E; Hercogová J; Unemo M
    Clin Microbiol Infect; 2020 Feb; 26(2):207-212. PubMed ID: 31419483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro assessment of gentamicin and azithromycin-based combination therapy against Neisseria gonorrhoeae isolates in India.
    Sood S; Agarwal SK; Singh R; Gupta S; Sharma VK
    J Med Microbiol; 2019 Apr; 68(4):555-559. PubMed ID: 30869583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial.
    Ross JDC; Brittain C; Cole M; Dewsnap C; Harding J; Hepburn T; Jackson L; Keogh M; Lawrence T; Montgomery AA; Roberts TE; Sprange K; Tan W; Thandi S; White J; Wilson J; Duley L;
    Lancet; 2019 Jun; 393(10190):2511-2520. PubMed ID: 31056291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Arm Open-Label Clinical Trial of Two Grams of Aztreonam for the Treatment of Neisseria gonorrhoeae.
    Barbee LA; Soge OO; Ocbamichael N; LeClair A; Golden MR
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.
    Brown LB; Krysiak R; Kamanga G; Mapanje C; Kanyamula H; Banda B; Mhango C; Hoffman M; Kamwendo D; Hobbs M; Hosseinipour MC; Martinson F; Cohen MS; Hoffman IF
    Sex Transm Dis; 2010 Mar; 37(3):169-72. PubMed ID: 19901860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.
    Brittain C; Childs M; Duley L; Harding J; Hepburn T; Meakin G; Montgomery AA; Tan W; Ross JD
    Trials; 2016 Nov; 17(1):558. PubMed ID: 27881151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
    Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
    Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stably high azithromycin resistance and decreasing ceftriaxone susceptibility in Neisseria gonorrhoeae in 25 European countries, 2016.
    Day MJ; Spiteri G; Jacobsson S; Woodford N; Amato-Gauci AJ; Cole MJ; Unemo M;
    BMC Infect Dis; 2018 Dec; 18(1):609. PubMed ID: 30509194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Persistent and Possibly Treatment Resistant Pharyngeal Gonorrhea.
    Levy V; Pandori M; Berrada ZL; Relucio KI; Lopez TP; Samuel MC; Park IU
    Sex Transm Dis; 2016 Apr; 43(4):258-9. PubMed ID: 26967304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.